drugset / Trial / NCT00631865

Autologous Transplantation of Melanocytes for Treatment of Vitiligo Skin

NCT00631865 ↗

Phase 3 Completed 300 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of melanocytes in patients with vitiligo.

Timeline

Start
2009-02
Primary completion
2015-02
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Melanocyte transplantation Cell therapy — Other

Indications